Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer
Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced […]
ADARx Pharmaceuticals Raises $46 Million in Financing as Lead Product Enters the Clinic
ADARx Pharmaceuticals, a clinical-stage biotechnology company developing RNA-targeting therapeutics, has announced the close of a […]
Vector BioPharma and iBET Collaborate to Develop High-throughput Analytical Methods and Scalable Processes for Gene Delivery
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and […]
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Biocytogen Pharmaceuticals (Beijing), a clinical-stage biotechnology company with a focus on the antibody discovery and […]
Phio Pharmaceuticals Announces New Clinical Program to Study PH-762 for the Treatment of Cutaneous Squamous Cell Carcinoma
Phio Pharmaceuticals has announced it expects to file an IND in the US in the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more